Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safety, tolerability, and efficacy of AQUAVAN® Injection when used for mild-to-moderate sedation in patients undergoing minor surgical procedures.


Clinical Trial Description

Randomized, open label, multi-center,midazolam adaptive dose ranging study, in which several dose levels of AQUAVAN® Injection and fentanyl citrate injection will be investigated to produce a desired sedation level in patients undergoing minor surgical and/or therapeutic procedures. A desired sedative dose/dose range and dosing paradigm will be identified based on pre-set criteria using the Modified Observer's Assessment of Alertness/Sedation (OAA/S). The desired sedative dose/dose range and dosing paradigm of AQUAVAN® Injection is defined as one that consistently provides mild to moderate sedation (Modified OAA/S between 2 and 4 inclusive) in majority of patients who are pre-medicated with fentanyl citrate injection.

Midazolam is the most widely used i.v. agent for minimal-to-moderate sedation. The dose range of midazolam to induce minimal to moderate sedation was based on standard clinical practice.

[new paragraph] All patients were pre-medicated with fentanyl citrate as an analgesic.

The outpatient setting has become increasingly popular for various types of medical procedures requiring sedation. In outpatient minor surgical procedures, sedation agents are used to provide mild-to-moderate sedation and are used with other medicines for pain management. Surgeons have searched for alternative treatments to use in the outpatient setting that would provide a faster recovery time with minimal post-procedure amnesia. This injection is used following pretreatment with fentanyl citrate for pain management. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00209560
Study type Interventional
Source Eisai Inc.
Contact
Status Terminated
Phase Phase 3
Start date October 2004
Completion date March 2005

See also
  Status Clinical Trial Phase
Recruiting NCT06014203 - Examination of Edema After Arthroscopic Shoulder Surgery
Not yet recruiting NCT05995795 - Arthroscopic Release Of Shoulder Internal Rotation Contracture In Brachial Plexus Palsy
Not yet recruiting NCT03688529 - Analyzing the Noxious Autonomic Response During Shoulder Arthroscope Surgery
Recruiting NCT03699046 - Evaluating the Effectiveness of Subchondroplasty for Treating Bone Marrow Lesions of the Knee N/A
Completed NCT00492609 - Medical and Economical Evaluation of Computer-assisted Reconstruction of the Anterior Cruciate Ligament (ACL) N/A
Not yet recruiting NCT05269095 - Adductor Canal Block Combined With IPACK vs Genicular Nerves Block in Knee Arthroscopy N/A
Completed NCT02184702 - Effects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy N/A
Recruiting NCT04855877 - Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis Phase 4
Completed NCT03427775 - Multimodal Analgesia After Shoulder Arthroscopy
Enrolling by invitation NCT01052233 - Development of Knee Osteoarthritis After Arthroscopic Partial Resection of Degenerative Meniscus Tear Phase 4
Completed NCT01169389 - Analgesic Control Following Knee Arthroscopy N/A
Completed NCT00633438 - Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery Phase 4
Recruiting NCT04461431 - Clinical Study of Posterolateral Structure of Knee Joint Under Arthroscopy N/A
Not yet recruiting NCT03327337 - Arthroscopic Assisted Balloon Tibioplasty for the Treatment of Schatzker II-IV Tibial Plateau Fractures N/A
Completed NCT00633386 - Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery Phase 4
Not yet recruiting NCT05222334 - Ultrasound-Guided Extrafascial Versus Intrafascial Interscalene Brachial Plexus Block in Shoulder Arthroscopy N/A
Completed NCT05165836 - Dexmedetomidine as Adjuvant in Erector Spinae Plane Block After Shoulder Arthroscopy N/A
Recruiting NCT06208774 - Pericapsular Nerve Group Block vs Interscalene Block for Shoulder Arthroscopy N/A
Recruiting NCT05646654 - Interscalene Block Versus Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia N/A
Active, not recruiting NCT04178538 - The Effect of Fertilized ACL Technique on Outcomes of ACL Reconstruction in Young Adults N/A